“Eat your peas!” While those words may be rooted in love when your mother says them, love is the last […]
With World Intellectual Property (IP) Day here, it is important to recognize recent wins for IP and its role […]
The FCC has been saddling Internet service providers with harmful regulation from multiple angles, including its upcoming vote to […]
Missourians know small and family-owned businesses are the main drivers of our state economy. Small businesses in the Show-Me State […]
Though the federal statute authorizing the grant money expressly forbids the administration from regulating rates through a preset price or […]
Welcome back to Higher Ed on the Hill, where we break down the top policies driving higher education policy. On […]
Alexandria, Virginia — Today CASE once again voiced strong opposition to the Biden Administration’s efforts to engulf the internet […]
In a little-known skirmish coined the “Rum Wars,” the tranquil Caribbean waters have become the backdrop for an economic tussle […]
An unmistakable trend has taken hold in higher education, with more students turning their backs away from the traditional four-year […]
For decades, politicians like Vermont Senator Bernie Sanders have been calling for a national takeover of healthcare. Though this […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/